E-cadherin: A potential biomarker in cancer and a therapeutic target
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025-11 · 1880 (6) · 189466
DOI: 10.1016/j.bbcan.2025.189466 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025-11. Verfasst von Puja Kumari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, West Bengal, India. Hauptthemen laut MEDLINE: Neoplasms, Cadherins, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 194 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Indian Institute of Technology Kharagpur, Science and Engineering Research Board.
Abstract (Originalsprache)
Tumorigenesis is a complex, multifaceted process that deregulates normal cellular functions, including cell growth, proliferation, and apoptosis. The primary factors driving tumorigenesis include the activation of oncogenes, inhibition of tumor suppressor genes, and the disruption of cell-cell contact. E-cadherin, a critical component of adherens junctions, plays an integral role in cell adhesion, maintaining tissue integrity, and contributing to developmental processes. E-cadherin facilitates the regulation of proliferation through contact inhibition under physiological conditions, acting as a tumor suppressor, and the alterations in E-cadherin expression are a major driving force in the development of various cancers. However, ongoing research has revealed the significance of E-cadherin in cancer progression, emphasizing its functional duality in tumorigenesis. This review summarizes E-cadherin's diverse and complex functions in various cancers, the underlying molecular mechanisms, and its role as a potential cancer biomarker across different cancer types. Further, we highlight numerous therapeutic strategies designed to target E-cadherin expression to treat various cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, West Bengal, India.
- Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, West Bengal, India; Present address: School of Food Science and Nutrition, University of Leeds, Woodhouse Lane, Lee…
- Department of Bioscience and Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur 721302, West Bengal, India. Electronic address: dibyendu.samanta@iitkgp.ac.in.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Indian Institute of Technology Kharagpur
- Science and Engineering Research Board
Zitieren
APA
Kumari, P., Dash, S., & Samanta, D. (2025). E-cadherin: A potential biomarker in cancer and a therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1880(6), 189466. https://doi.org/10.1016/j.bbcan.2025.189466
Vancouver
Kumari P, Dash S, Samanta D. E-cadherin: A potential biomarker in cancer and a therapeutic target. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2025;1880(6):189466. doi:10.1016/j.bbcan.2025.189466
BibTeX
@article{Kumari2025,
author = {Kumari, Puja and Dash, Sagarika and Samanta, Dibyendu},
title = {E-cadherin: A potential biomarker in cancer and a therapeutic target},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2025},
volume = {1880},
number = {6},
pages = {189466},
doi = {10.1016/j.bbcan.2025.189466}
}
EUVIMED